Lyrica is approved by the US Food and Drug Administration to treat the following disorders:
  • Diabetic peripheral neuropathy
  • Postherpetic neuralgia
  • Fibromyalgia
  • Partial seizures in adults (adjunctive)

In addition it is commonly used 'off-label' (which means that it is not formally approved by the US FDA but has shown good anecdotal efficacy in treating the disorder) for the following disorders:
  • Generalized anxiety disorder (Formally approved for this use in the European Union and Russia)
  • Panic disorder
  • Social anxiety disorder